Reports of Radiotherapy and Oncology

Published by: Kowsar

Prognostic Significance of Thrombocytosis in Patients with Locally Advanced Cervical Carcinoma Treated with Chemoradiotherapy

Nanda Ramanand 1 , Shamsundar Sunkappa Dayashankara 1 , * , Aradhana Katke 1 and Thejaswini Boraiah 1
Authors Information
1 Radiation Oncology, Kidwai Cancer Institute, Bangalore, India
Article information
  • Reports of Radiotherapy and Oncology: December 31, 2018, 5 (1); e85384
  • Published Online: February 25, 2019
  • Article Type: Research Article
  • Received: October 15, 2018
  • Revised: January 18, 2019
  • Accepted: January 24, 2019
  • DOI: 10.5812/rro.85384

To Cite: Ramanand N, Sunkappa Dayashankara S, Katke A, Boraiah T. Prognostic Significance of Thrombocytosis in Patients with Locally Advanced Cervical Carcinoma Treated with Chemoradiotherapy, Rep Radiother Oncol. 2018 ; 5(1):e85384. doi: 10.5812/rro.85384.

Copyright © 2018, Reports of Radiotherapy and Oncology. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Riess L. Zur pathologischen anatomic des blutes. Arch Anat Physiol Wissenschr Med. 1872:39237-49.
  • 2. Costantini V, Zacharski LR, Moritz TE, Edwards RL. The platelet count in carcinoma of the lung and colon. Thromb Haemost. 1990;64(4):501-5. doi: 10.1055/s-0038-1647347. [PubMed: 1964750].
  • 3. Nakano T, Fujii J, Tamura S, Hada T, Higashino K. Thrombocytosis in patients with malignant pleural mesothelioma. Cancer. 1986;58(8):1699-701. doi: 10.1002/1097-0142(19861015)58:8<1699::AID-CNCR2820580820>3.0.CO;2-B. [PubMed: 3019510].
  • 4. Hernandez E, Lavine M, Dunton CJ, Gracely E, Parker J. Poor prognosis associated with thrombocytosis in patients with cervical cancer. Cancer. 1992;69(12):2975-7. doi: 10.1002/1097-0142(19920615)69:12<2975::AID-CNCR2820691218>3.0.CO;2-A. [PubMed: 1591690].
  • 5. Rodriguez GC, Clarke-Pearson DL, Soper JT, Berchuck A, Synan I, Dodge RK. The negative prognostic implications of thrombocytosis in women with stage IB cervical cancer. Obstet Gynecol. 1994;83(3):445-8. [PubMed: 8127540].
  • 6. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J. 1996;9(9):1826-30. doi: 10.1183/09031936.96.09091826. [PubMed: 8880098].
  • 7. Zeimet AG, Marth C, Muller-Holzner E, Daxenbichler G, Dapunt O. Significance of thrombocytosis in patients with epithelial ovarian cancer. Am J Obstet Gynecol. 1994;170(2):549-54. doi: 10.1016/S0002-9378(94)70225-X. [PubMed: 8116711].
  • 8. Levin J, Conley CL. Thrombocytosis associated with malignant disease. Arch Intern Med. 1964;114:497-500. doi: 10.1001/archinte.1964.03860100079008. [PubMed: 14184638].
  • 9. Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: The secrets of tumor self-promotion. Blood. 2014;124(2):184-7. doi: 10.1182/blood-2014-03-562538. [PubMed: 24868077]. [PubMed Central: PMC4093679].
  • 10. Hernandez E, Donohue KA, Anderson LL, Heller PB, Stehman FB. The significance of thrombocytosis in patients with locally advanced cervical carcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2000;78(2):137-42. doi: 10.1006/gyno.2000.5838. [PubMed: 10926792].
  • 11. Lopes A, Daras V, Cross PA, Robertson G, Beynon G, Monaghan JM. Thrombocytosis as a prognostic factor in women with cervical cancer. Cancer. 1994;74(1):90-2. doi: 10.1002/1097-0142(19940701)74:1<90::AID-CNCR2820740116>3.0.CO;2-0. [PubMed: 8004588].
  • 12. Kawano M, Mabuchi S, Matsumoto Y, Sasano T, Takahashi R, Kuroda H, et al. Prognostic significance of pretreatment thrombocytosis in cervical cancer patients treated with definitive radiotherapy. Int J Gynecol Cancer. 2015;25(9):1656-62. doi: 10.1097/IGC.0000000000000533. [PubMed: 26332391].
  • 13. Hernandez E, Heller PB, Whitney C, Diana K, Delgado G. Thrombocytosis in surgically treated stage IB squamous cell cervical carcinoma (A Gynecologic Oncology Group study). Gynecol Oncol. 1994;55(3 Pt 1):328-32. doi: 10.1006/gyno.1994.1300. [PubMed: 7835768].
  • 14. Sharma D, Singh G. Thrombocytosis in gynecological cancers. J Cancer Res Ther. 2017;13(2):193-7. doi: 10.4103/0973-1482.189234. [PubMed: 28643732].
  • 15. Cheng J, Zeng Z, Ye Q, Zhang Y, Yan R, Liang C, et al. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: A systematic review and meta-analysis. Oncotarget. 2017;8(15):24327-36. doi: 10.18632/oncotarget.15358. [PubMed: 28212582]. [PubMed Central: PMC5421850].
  • 16. Kozasa K, Mabuchi S, Komura N, Yokoi E, Hiromasa K, Sasano T, et al. Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: A single institutional study and literature review. Oncotarget. 2017;8(33):55394-404. doi: 10.18632/oncotarget.19560. [PubMed: 28903428]. [PubMed Central: PMC5589667].
  • 17. Tuszynski GP, Nicosia RF. The role of thrombospondin-1 in tumor progression and angiogenesis. Bioessays. 1996;18(1):71-6. doi: 10.1002/bies.950180113. [PubMed: 8593167].
  • 18. Arnoletti JP, Albo D, Granick MS, Solomon MP, Castiglioni A, Rothman VL, et al. Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells. Cancer. 1995;76(6):998-1005. doi: 10.1002/1097-0142(19950915)76:6<998::AID-CNCR2820760613>3.0.CO;2-0. [PubMed: 8625226].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments